Open AccessStudy of platelet aggregation in acute coronary syndrome with special reference to metabolic syndrome
Author(s) -
Rudrajit Paul,
Amit Kumar Banerjee,
Shantanu Guha,
Utpal Chaudhuri,
Sayantani Ghosh,
Jayati Mondal,
Ranjana Bandyopadhyay
Publication year - 2013
Publication title -
international journal of applied and basic medical research/international journal of applied and basic medical research
Language(s) - English
Resource type - Journals
eISSN - 2248-9606
pISSN - 2229-516X
DOI - 10.4103/2229-516x.117086
Subject(s) - acute coronary syndrome , metabolic syndrome , platelet aggregation , medicine , cardiology , platelet , myocardial infarction , obesity
Antiplatelet drug resistance increases the risk of adverse events like stent thrombosis in acute coronary syndrome (ACS). Metabolic syndrome (MS) is a prothrombotic state and presence of MS further increases the risk of antiplatelet drug resistance.